Related Experiment Videos
Bilateral response after unilateral subconjunctival bevacizumab injection in a child with Stevens-Johnson syndrome
Siddharth Kesarwani1, Srikant Kumar Sahu, Soumyava Basu
1Miriam Hyman Children's Eye Care Centre, L V Prasad Eye Institute, Bhubaneswar, Orissa, India.
Abstract:
Bevacizumab is widely used for several ocular conditions, including age-related macular degeneration, diabetic retinopathy, corneal neovascularization, neovascular glaucoma, and retinopathy of prematurity. We describe a 14-year-old patient with Stevens-Johnson syndrome in whom subconjunctival injection of bevacizumab in one eye caused bilateral regression of corneal neovascularization.